Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
  • Subscribe to newsletter
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
    • CGHE Annual Reports
      • Annual Report 2022
      • Annual Report 2021
      • Annual Report 2020
    • CGHE Publications
  • Partner programs
    • Programs search
  • Data dashboards
    • Country data dashboards
    • National Hepatitis Elimination Profiles
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • HCV Treatment in Pregnancy
      • Tip-HepC Registry
      • TiP-HepC Systematic Review Results
    • Action Plan Systematic Review
    • Hepatitis B Birth Dose Vaccine Systematic Review
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing Systematic Review
    • COVID-19 Evidence Hub
      • COVID-19 and Liver Disease Synthesis
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
    • Innovations in Hepatitis Elimination (CLD Series)
      • TEST DRAFT PAGE
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
    • Hepatitis Elimination Help Desk
  • Resources
    • Expanding access to hepatitis C prevention, testing, and treatment in prisons
    • Hep C Elimination Tool
      • Access the Tool
      • User Guide
      • Frequently Asked Questions
    • Technical Assistance Help Desk and Frequently Asked Questions
    • Toolkit: Birth Dose Vaccination in Africa
    • Search resources
  • Elimination champions
  • News
    • Announcements
    • News search
    • HepEquity Blog
    • Elimination Champions
    • Events
    • Newsletters
    • Press releases
    • Publications
  • Webinars & Events
    • HCV in Prisons
    • Treatment of HCV in Pregnancy for Hepatitis (TiP-HepC)
      • Webinar 1: Challenges
      • Webinar 2: Strategies
      • Webinar 3: Recommendations
    • NIH "Moving from Hepatitis Discovery to Elimination"
    • Hep Test
    • Linkage to care
    • Strategic Information Collaborative
    • Regional Hepatitis Elimination
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • Search webinars
  • UN Group of Friends
  1. Home
  2. Evidence base
  3. Evidence base search

Evidence base articles search

The evidence base was developed using rigorous review methods for the identification and quality assessment of eligible systematic reviews and guideline and policy documents. In response to identified global research priorities, the evidence base currently presents characteristics of interventions to inform implementation of hepatitis B birth dose , HCV testing and hepatitis B and C action plans. Updates to the evidence base are planned to address subsequent priorities.

Edit

Evidence base search

Filter

  • (-) HCV treatment in pregnancy ("Tip-HepC")
  • Hepatitis B
  • Hepatitis C
  • Coinfection with HIV
  • HBV testing and linkage to care
  • HCV testing and linkage to Care
  • HCV treatment
  • Hepatitis B Vaccination
  • Hep B birth-dose vaccination
  • Linkage to care
  • Prevention mother-child transmission
  • Screening and diagnosis
  • Screening of pregnant women
  • Strategic data analysis
  • Testing
  • Treatment
  • Treatment (direct or referral)
  • Adults
  • Children (> one year < 10 years of age)
  • Children 5-11
  • Children 12-17
  • Children Under 5
  • Infants (less than one year of age)
  • Persons who inject drugs
  • Pregnant women
  • Case-control
  • Case report
  • Cost-effective analysis
  • Cross-sectional
  • Guidance
  • Laboratory study
  • Mathematical modelling
  • Meta-Analysis
  • Narrative Review
  • Prospective cohort
  • Recommendations
  • Retrospective chart review
  • Retrospective cohort
  • Systematic Review
  • Egypt
  • European Union
  • Global
Displaying 1 - 12 of 98
  • Hospital-visiting pregnant women signal an increased spread of hepatitis C infection in Khyber Pakhtunkhwa region of Pakistan

    2017 Oct 10
    Virol J

    14

    195
  • Hepatitis C infection among pregnant women in central Poland: Significance of epidemiological anamnesis and impact of screening tests to detect infection

    2019 Mar
    Adv Clin Exp Med.

    28

    313-318
  • Hepatitis C in HIV-infected individuals: a systematic review and meta-analysis of estimated prevalence in Africa

    2016 Jun 9
    J Int AIDS Soc

    19

    20711
  • Hepatitis C Virus in Pregnancy: A Systematic Review of the Literature

    2021 Aug
    Am J Perinatol.

    38

    e1-e13
  • Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland

    2016 Jan 1
    J Virus Erad

    2

    52-4
  • Hepatitis B and C in Pregnant Women Attended by a Prenatal Program in an University Hospital in Rio de Janeiro, Brazil: Retrospective Study of Seroprevalence Screening

    2018 Jul-Sep
    Arq Gastroenterol.

    55

    267-273
  • Maternal risk factors associated with inadequate testing and loss to follow-up in infants with perinatal hepatitis C virus exposure

    2021
    J Neonatal Perinatal Med

    14

    123-129
  • Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care

    2021 Sep
    Am J Perinatol

    38

    1109-1116
  • Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States

    2021 Nov 2
    Clin Infect Dis

    73

    e3355-e3357
  • Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study

    2020 Sept
    Lancet Microbe

    1

    e200-e208
  • Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey

    2019 Mar
    Turk J Gastroenterol

    30

    260-265
  • Cost-effectiveness of screening for hepatitis C virus: a systematic review of economic evaluations

    2016 Sep 6
    BMJ Open

    6

    e011821

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ››
  • Last page Last »

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2023 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media
q